Immune Imprinting Across Respiratory Virus Infection, Vaccination, and Passive Immunization: Rethinking ‘Original Antigenic Sin’ in Influenza, SARS-CoV-2, and RSV
Viruses · 2026
DOI: 10.3390/v18101155 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2026. Verfasst von Agnieszka Szuster-Ciesielska. Beteiligte Einrichtung: Department of Virology and Immunology, Institute of Biological Sciences, Maria Curie-Skłodowska University, Akademicka 19, 20-032 Lublin, Poland. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, SARS-CoV-2, Influenza, Human, COVID-19. Die Arbeit nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Immune imprinting shapes every subsequent response to antigenically related pathogens and is now central to designing updated vaccines for influenza, SARS-CoV-2, and respiratory syncytial virus (RSV). The label “Original Antigenic Sin” has framed imprinting as a fixed liability, but recent germinal-center, B-cell repertoire, and epidemiological data show that the effect is neither uniformly harmful nor irreversible. This review distinguishes cross-reactive immune memory from immune imprinting, defined here as a preferential bias toward the first-encountered antigen. Prior exposure can provide useful cross-reactive memory, but available evidence generally does not show that first-antigen bias itself improves protection relative to an equivalent unbiased memory response. We therefore use a hypothesis-generating conceptual framework to examine how antigenic distance, conserved-epitope accessibility, and exposure interval may influence both the usefulness of recalled memory and the extent to which imprinting restricts recruitment of responses to later antigens. The framework organizes existing observations and is not intended to predict imprinting outcomes ex ante. We discuss recent quantitative models that explicitly formalize competition between memory and de novo responses as complementary, pathogen-specific approaches. Across influenza and SARS-CoV-2, early exposure can establish cross-reactive memory associated with subsequent heterologous protection, while preferential recall of the priming antigen may limit responses to novel epitopes. For RSV, the effects of maternal vaccination and passive antibodies on subsequent active immune memory remain uncertain. Immunogen engineering, schedule adjustment, adjuvant selection, and cohort-tailored strategies may broaden pre-existing memory toward conserved protective epitopes and reduce restrictive first-antigen bias.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Virology and Immunology, Institute of Biological Sciences, Maria Curie-Skłodowska University, Akademicka 19, 20-032 Lublin, Poland.
ORCID-Profile: Agnieszka Szuster-Ciesielska
Zitieren
APA
Szuster-Ciesielska, A. (2026). Immune Imprinting Across Respiratory Virus Infection, Vaccination, and Passive Immunization: Rethinking ‘Original Antigenic Sin’ in Influenza, SARS-CoV-2, and RSV. Viruses. https://doi.org/10.3390/v18101155
Vancouver
Szuster-Ciesielska A. Immune Imprinting Across Respiratory Virus Infection, Vaccination, and Passive Immunization: Rethinking ‘Original Antigenic Sin’ in Influenza, SARS-CoV-2, and RSV. Viruses. 2026. doi:10.3390/v18101155
BibTeX
@article{SzusterCiesielska2026,
author = {Szuster-Ciesielska, Agnieszka},
title = {Immune Imprinting Across Respiratory Virus Infection, Vaccination, and Passive Immunization: Rethinking ‘Original Antigenic Sin’ in Influenza, SARS-CoV-2, and RSV},
journal = {Viruses},
year = {2026},
doi = {10.3390/v18101155}
}
EUVIMED